A Prostate Cancer Proteomics Database for SWATH-MS based Protein Quantification

ABSTRACT: Prostate cancer is the third most frequent cancer in men worldwide, with a notable increase in prevalence over the last two decades. The PSA is the only well-established protein biomarker for prostate cancer diagnosis, staging, and sur-veillance. It frequently leads to inaccurate diagnosis and overtreatment since it is an organ-specific biomarker rather than a tumour-specific biomarker. As a result, one of the primary goals of prostate cancer proteome research is to iden-tify novel biomarkers that can be used with or instead of PSA, particularly in non-invasive blood samples. Thousands of peptides or assays were detected in blood samples from patients with low to high-grade prostate cancer and healthy individuals, allowing data processing of sequential window acquisition of all theoretical mass spectra (SWATH-MS). By assisting in the detection of prostate cancer biomarkers in blood samples, this useful resource will improve our un-derstanding of the role of proteomics in prostate cancer diagnosis and risk assessment.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

DISEASE(S): Prostate Adenocarcinoma

SUBMITTER: AMMARA MUAZZAM  

LAB HEAD: Paul Townsend

PROVIDER: PXD028651 | Pride | 2021-12-20

REPOSITORIES: Pride